These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 20147496)

  • 1. Comparison of three automated immunoassay methods for the determination of Epstein-Barr virus-specific immunoglobulin M.
    Berth M; Bosmans E
    Clin Vaccine Immunol; 2010 Apr; 17(4):559-63. PubMed ID: 20147496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Abbott Architect
    François C; Segard C; Bouvier M; Stefanski M; Pannier C; Zawadzki P; Roussel C; Hecquet D; Duverlie G; Brochot E; Castelain S
    Diagn Microbiol Infect Dis; 2018 Feb; 90(2):96-101. PubMed ID: 29198371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Abbott Architect, Siemens Immulite, bioMerieux Vidas, and Euroimmune assays for determination of Epstein-Barr virus serological diagnosis.
    Appak O; Ozkaratas MH; Sayiner AA
    J Med Virol; 2021 Nov; 93(11):6309-6316. PubMed ID: 34375007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a multiplex flow immunoassay for detection of epstein-barr virus-specific antibodies.
    Binnicker MJ; Jespersen DJ; Harring JA; Rollins LO; Beito EM
    Clin Vaccine Immunol; 2008 Sep; 15(9):1410-3. PubMed ID: 18632919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analytical performance evaluation of the Elecsys Epstein-Barr virus immunoassay panel.
    Schulte-Spechtel U; Berth M; Lauseker-Hao Y; Meyer-Schlinkmann K; Bohnert M; Jochum S; Schuhmann K
    Diagn Microbiol Infect Dis; 2021 Nov; 101(3):115443. PubMed ID: 34304105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of two commercially available automated immunoassays for the determination of Epstein-Barr virus serological status.
    Lupo J; Germi R; Semenova T; Buisson M; Seigneurin JM; Morand P
    Clin Vaccine Immunol; 2012 Jun; 19(6):929-34. PubMed ID: 22539474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a multiplexed bead assay for assessment of Epstein-Barr virus immunologic status.
    Klutts JS; Liao RS; Dunne WM; Gronowski AM
    J Clin Microbiol; 2004 Nov; 42(11):4996-5000. PubMed ID: 15528686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Architect Epstein-Barr Virus (EBV) viral capsid antigen (VCA) IgG, VCA IgM, and EBV nuclear antigen 1 IgG chemiluminescent immunoassays for detection of EBV antibodies and categorization of EBV infection status using immunofluorescence assays as the reference method.
    Corrales I; Giménez E; Navarro D
    Clin Vaccine Immunol; 2014 May; 21(5):684-8. PubMed ID: 24623623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation the Architect EBV VCA IgM, VCA IgG, and EBNA-1 IgG chemiluminescent immunoassays to assess EBV serostatus prior transplantation.
    Maylin S; Feghoul L; Salmona M; Herda A; Mercier-Delarue S; Simon F; Legoff J
    J Med Virol; 2017 Nov; 89(11):2003-2010. PubMed ID: 28661055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic Performance and Comparative Evaluation of the Architect, Liaison, and Platelia Epstein-Barr Virus Antibody Assays.
    Park Y; Park BG; Ha J; Kim HS
    Ann Lab Med; 2018 Sep; 38(5):458-465. PubMed ID: 29797817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the abbot Architect(™) epstein-barr virus viral capsid antigen IgM, viral capsid antigen IgG and nuclear antigen IgG assays in a pediatric and adult population.
    Grandjean Lapierre S; Vallières E; Rabaamad L; Labrecque M; Chartrand C; Renaud C
    J Clin Virol; 2016 Aug; 81():1-5. PubMed ID: 27258036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Performance of the VIDAS automated immunoassay for the determination of Epstein-Barr virus serological status].
    De Ory F; Guisasola ME; Sanz JC; García-Bermejo I
    Enferm Infecc Microbiol Clin; 2012 Dec; 30(10):618-20. PubMed ID: 22854635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of Epstein-Barr virus-specific antibodies by an automated enzyme immunoassay. Performance evaluation and cost analysis.
    Tang YW; Helgason JA; Wold AD; Smith TF
    Diagn Microbiol Infect Dis; 1998 Aug; 31(4):549-54. PubMed ID: 9764394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of three different assays for the assessment of Epstein Barr Virus immunological status.
    Altuglu I; Bozkurt H; Samlioglu P; Zeytinoglu A
    New Microbiol; 2007 Oct; 30(4):393-8. PubMed ID: 18080674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Elecsys and Liaison immunoassays to determine Epstein-Barr virus serological status using further diagnostic approaches to clarify discrepant results.
    Lupo J; Tsougaev M; Blachier S; Chovelon G; Truffot A; Leroy C; Giai J; Epaulard O; Germi R; Morand P
    J Med Virol; 2023 Jan; 95(1):e28166. PubMed ID: 36137986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence-based approach for interpretation of Epstein-Barr virus serological patterns.
    Klutts JS; Ford BA; Perez NR; Gronowski AM
    J Clin Microbiol; 2009 Oct; 47(10):3204-10. PubMed ID: 19656988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic performance of a new automated heterophile antibody test in adults and children.
    Klutts JS; Wu AH; Smith A; Yen-Lieberman B; Gronowski AM
    Diagn Microbiol Infect Dis; 2008 Jul; 61(3):351-3. PubMed ID: 18420370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of 12 commercial tests for detection of Epstein-Barr virus-specific and heterophile antibodies.
    Bruu AL; Hjetland R; Holter E; Mortensen L; Natås O; Petterson W; Skar AG; Skarpaas T; Tjade T; Asjø B
    Clin Diagn Lab Immunol; 2000 May; 7(3):451-6. PubMed ID: 10799460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reliability of the Siemens Enzygnost and Novagnost Epstein-Barr virus assays for routine laboratory diagnosis: agreement with clinical diagnosis and comparison with the Merifluor Epstein-Barr virus immunofluorescence assay.
    Kreuzer C; Nabeck KU; Levy HR; Daghofer E
    BMC Infect Dis; 2013 Jun; 13():260. PubMed ID: 23731557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of four commercial systems for the diagnosis of Epstein-Barr virus primary infections.
    de Ory F; Guisasola ME; Sanz JC; García-Bermejo I
    Clin Vaccine Immunol; 2011 Mar; 18(3):444-8. PubMed ID: 21191077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.